The Italy Peptide Receptor Radionuclide Therapy (PRRT) market is estimated to be valued at US$ 591.83 Mn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Peptide receptor radionuclide therapy or PRRT is a form of nuclear medicine therapy which is used for treating...
0 Commentarios
0 Acciones
825 Views
0 Vista previa